Tesla, Inc. (NASDAQ: TSLA) — Initiating Coverage CAUTIOUSScenario Fair Value$235

1 · Summary & Verdict

Tesla is deliberately trading near-term earnings for an autonomy and robotics option — and we think that is the right call for the company. At $313 it is the wrong call for the shareholder: you are paid for the bull case and carry ~80% downside to the bear. Cautious, Scenario Fair Value $235.

THE THREE RISKS THAT MATTER

2 · Investment Thesis

1. The growth re-acceleration is real, and it is the strongest part of the bull case

After a genuinely bad 2025 — revenue down 3% to $94.8B, deliveries down 9% to 1.64M, operating income down 38% — Tesla has re-accelerated hard: +16% in Q1-26 and +26% in Q2-26, with Q2 deliveries up 25% to a record 480,126. Management says it is production-constrained on electronics and batteries rather than demand-constrained, inventory fell from 27 to 15 days of supply, and the order backlog is the largest ever. Services and other revenue grew 50% to $4,581M, and energy storage deployments rose 41% to 13.5 GWh. We model FY2026E revenue of $114B (+20%) and a 19.6% CAGR to $232B by FY2030E. We are not bearish on Tesla's revenue.

• Q2-26 revenue $28.2B (+26% y/y); H1-26 revenue $50.6B on 838,149 deliveries
• Services & other +50% y/y; FSD subscriptions 1.48M (+56%); ~12B cumulative FSD miles
• Cybercab in continuous production since April 2026; Semi and Megapack 3 both guided to 2026
• FY2026E revenue $114B → FY2030E $232B (19.6% CAGR) in our base case

2. But the earnings base has been hollowed out, and depreciation has not arrived yet

Q2-26 operating margin was 1.4%, down from 4.1%. Gross margin fell to 16.8%. Opex grew 47%. Free cash flow was -$1,092M against capex of $5,789M. The forward problem is arithmetic rather than narrative: over $70B of capex across 2026-27 has to be depreciated, and we model D&A tripling from $6.3B to $18.5B between FY2025A and FY2030E. In our base case free cash flow is -$7.2B in FY2026E, barely positive at +$1.4B in FY2027E, and does not reach a comfortable level until FY2028E. FY2026E GAAP EPS of $0.77 is below FY2025A's $1.08 and less than a fifth of FY2023A's $4.30. The company is spending like a hyperscaler while earning like a marginal industrial.

• Q2-26: opex $4,353M (+47%), R&D $2,371M (+49%), SBC $1,151M and rising
• FY2026E capex >$25B guided vs $8.5B in FY2025A; up to $30B of borrowing planned
• Our D&A path: $6.3B FY25A → $10.5B FY27E → $18.5B FY30E
• Our FCF path: -$7.2B FY26E → +$1.4B FY27E → +$12.2B FY28E

3. Autonomy is the entire valuation, and it is still measured in millions of miles

Everything above $100 per share is a claim on robotaxi and Optimus. The honest state of play: unsupervised robotaxi is live in seven metros with roughly 2.5M cumulative paid miles; Cybercab has produced test units but no customer deliveries; Optimus production is guided to start in 2026 with external commercialisation in 2027; and Tesla has never disclosed robotaxi unit economics. We estimate FSD and robotaxi software revenue at roughly $3.6B in FY2026E — about 3% of revenue — scaling to $24B by FY2030E in our base case. That is a genuinely large business being built. It is not yet a business that supports $1.18T of market value, and the disclosure needed to underwrite it does not exist.

• ~2.5M cumulative robotaxi paid miles; management targets 10% weekly growth domestically
• Over 55% of new North American deliveries included an FSD subscription at purchase
• Optimus: first-gen lines installed at Fremont; internal training use first, external 2027
• Our estimate: FSD + robotaxi revenue $3.6B FY26E → $24B FY30E (~10% of revenue)

4. Valuation: no method we can build reaches the price, and the bands say why that matters less than usual

A mid-cycle DCF at a 12.7% WACC returns roughly $64 per share with terminal value at 88% of enterprise value — which tells you the method has broken down, not that Tesla is worth $64. We therefore give the DCF a 10% weight and anchor on scenario-weighted FY2030E earnings power instead. At $313 the stock trades at ~61x our FY2030E EPS of $5.14 — four years forward — against an auto and mobility peer set at 5-16x forward earnings. Our football field puts $313 above the high end of four of five methods; it sits inside only the scenario range, and there only because the bull case is in it. Notably, Tesla is not expensive against its own history: P/S sits about 0.9σ above its 8-year mean and P/B almost exactly at the mean. That is the point. The bands cannot help you here, because Tesla's history is itself a history of paying for the future.

• Mid-cycle DCF ~$64/share; terminal value 88% of EV; sensitivity grid spans $48-104
• $313 = ~61x FY2030E EPS $5.14; ~290x trailing GAAP EPS of $1.08
• Scenario weighting: 25% bull $500 / 50% base $190 / 25% bear $60 → SFV $235
• Upgrade trigger: $180-200, or disclosed robotaxi unit economics at scale

3 · Financial Analysis

Tesla’s financial record over FY2023-FY2025 and the two quarters of 2026 reported so far tells a clear story: a business whose revenue has grown, stalled and re-accelerated, and whose margins have declined every single year since 2022.

Three observations. First, FY2023 net income of $14,997M is not comparable to anything — it includes a roughly $5.9B one-time non-cash release of a deferred tax asset valuation allowance. Underlying FY2023 earnings power was closer to $9-10B. Second, operating income has more than halved in two years while revenue was roughly flat, which is entirely an operating-expense story: opex grew 45% from $8,769M to $12,739M while gross profit fell 3%. Third, FY2025 free cash flow of $6,220M was the best of the three years — but only because capex fell to $8,527M. That is about to reverse violently.

The Q2-26 print in detail. This is the quarter that occasioned the initiation, and it deserves line-by-line treatment.

Reading the quarter. Record revenue was genuine: $28,236M, comfortably ahead of the roughly $26.4B expected, on a Q2 delivery record. Services growing 50% and storage deployments growing 41% are both real. The problem sits between gross profit and operating income. Gross profit grew 23% — slightly slower than revenue, as gross margin slipped 41 basis points to 16.8% — but operating expenses grew 47%, so operating income fell 57%. Roughly a third of that opex increase was stock-based compensation, which rose from $635M to $1,151M, driven largely by the 2025 CEO Performance Award.

Segment margins tell the rest. Automotive gross margin fell from 19.2% to 16.3% on warranty adjustments, higher interest rates and the end of tariff relief. Energy gross margin collapsed from 39.5% to 20.4% on tariffs. Services gross margin was 14%. Regulatory-credit revenue fell 67% to $146M from $439M — a near-100%-margin line, structurally impaired by the expiry of the $7,500 federal credit on 30 September 2025 and the zeroing of CAFE penalties.

The quality-of-earnings issue. GAAP net income of $1,114M sits well above operating income of $398M. The bridge is “other income (expense), net” of $590M, which includes a $1,005M unrealized gain on the SpaceX equity investment that Tesla purchased for $2,002M in Q1-26 — a roughly 50% markup within one quarter on an unlisted holding in a company sharing Tesla’s chief executive, partly offset by $312M of foreign-currency losses and a $112M digital-asset loss. Pre-tax income was $1,329M against a $201M tax provision, a 15.1% effective rate. Excluding the SpaceX mark, pre-tax income was approximately $324M and GAAP EPS was roughly $0.07 rather than $0.32. The disclosure is clear and the accounting is permitted; the point is that the headline earnings number for the quarter was substantially a valuation judgement about a private related party rather than a result of operations.

Also worth noting on quality: “Adjusted EBITDA” of $3,273M adds back $1,151M of stock-based compensation. On a conventional EBITDA basis — operating income plus D&A of $1,619M — the quarter produced $2,017M, a 7.1% margin. And deliveries of 480,126 exceeded production of 451,758, drawing inventory down from 27 to 15 days of supply. Over H1-26 combined, production of 860,144 against deliveries of 838,149 is a far less dramatic picture than Q2 in isolation.

Balance sheet: strong, and being levered deliberately. At 30 June 2026 Tesla held $43,524M of cash and short-term investments against $1,418M of current debt and $7,924M of long-term debt — total debt of $9,342M and net cash of approximately $34,182M, about $9 per share. Total assets were $148,524M and total stockholders’ equity $86,858M. Property, plant and equipment rose from $43,213M to $47,255M in the quarter as capex landed. Days sales outstanding were 13 and days payable outstanding 58, both healthy. There is no financial-distress argument here: Tesla can fund the announced programme from cash flow and existing liquidity, and management has signalled willingness to add up to $30B of debt to accelerate it.

Share count. Weighted-average diluted shares were 3,540M in Q2-26 against basic shares of 3,237M. Cover-page shares outstanding were 3,755,723,871 as of 16 April 2026, including 423,743,904 shares from the 2025 CEO Performance Award and 286,428,773 restricted shares subject to service-based vesting. Roughly 6% of the company therefore sits outside the current diluted count, and stock-based compensation of $1,151M per quarter and rising is the cash-equivalent cost of that overhang. We model diluted shares rising from 3,520M in FY2025A to 3,900M by FY2030E.

What the record establishes for the forward model. Revenue growth is real and re-accelerating. Gross margin has been remarkably stable in a narrow 17.9-18.2% band across three years — the volatility is all below the gross-profit line. Operating margin compression is an opex and mix story, not a manufacturing story. Free cash flow was healthy until capex tripled. And the earnings base into which the depreciation from $70B of 2026-27 investment will land is a 1.4% operating margin. Section 4 puts a five-year path on that.

4 · Projection Assumptions

Our FY2026E-FY2030E base case models Tesla as a company that grows revenue at a 19.6% compound rate while repairing margins slowly, because the capital being spent in 2026 and 2027 has to be depreciated before the revenue it enables arrives. FY2026E is anchored on reported H1 actuals — revenue of $50,623M, deliveries of 838,149, free cash flow of $352M — with only H2 modelled.

Revenue path ($B): 94.8 (FY25A) → 114.0 → 141.0 → 171.0 → 201.0 → 232.0. That is +20.2% in FY2026E and a 19.6% CAGR from FY2025A through FY2030E. FY2026E decomposes to automotive $81.5B (+17%), energy $13.6B (+7%), and services $18.8B (+50%). By FY2030E the mix shifts materially: automotive $142B (61% of revenue, down from 73% in FY2025A), services $58B (25%, up from 13%), energy $32B (14%).

Where we sit versus the street. Our FY2026E revenue of $114B is broadly in line with consensus following the Q2 beat; our FY2026E GAAP EPS of $0.77 is likely below consensus because we assume no further investment marks and model H2 gross margin below H1. Our FY2027E EPS of $1.27 is materially below the sell-side average, which we believe under-models the depreciation step-up from FY2026 capex. Few street models extend to FY2030E, so our $5.14 has no clean comparison — but it implies Tesla earning a 8.6% net margin on $232B of revenue, which is not a bearish assumption for a company at 11.4% operating margin.

Three assumptions to stress. First, capex duration — every additional year Tesla sustains $24B+ of capex pushes free-cash-flow breakeven out and adds roughly $2.5-3.0B to annual D&A two years later. Second, FSD and robotaxi revenue — every $5B of incremental FY2030E software revenue at a 60% incremental margin adds roughly $0.60 to FY2030E EPS, worth about $35 per share on a 57x exit multiple. Third, automotive gross margin — each 100 basis points on FY2030E automotive revenue is $1.4B of gross profit, or about $0.28 of EPS. These three sensitivities are the substance of the scenario fan in Section 5.

5 · Scenario Analysis

Tesla has the widest legitimate outcome distribution of any mega-cap equity we cover, and the scenario framework carries a 50% weight in our valuation precisely because that dispersion is the analytical problem. The sell-side illustrates the point: post-Q2-26 price targets run from $130 at Wells Fargo to $600 at Wedbush — a $470 spread on the same company, on the same disclosure, in the same week.

We hold three cases at 25% / 50% / 25%, blending to a Scenario Fair Value of $235.

Bull — $500 (25% probability). Autonomy and robotics land on schedule.

Robotaxi unit economics prove out during 2027 and Tesla scales from thousands to hundreds of thousands of revenue-generating autonomous vehicles by 2030. Cybercab runs near or above its 125,000-unit installed capacity with a second facility. FSD attach extends beyond the current 55% of new North American deliveries and internationalises as regulatory approvals accumulate. Optimus begins external commercialisation in 2028 and contributes meaningful revenue by 2030. An affordable model arrives and reopens the volume segment BYD currently owns.

Financially: revenue compounds at 28.8% to approximately $335B by FY2030E, gross margin reaches 32% as software and fleet revenue mix up, operating income reaches roughly $67B, and diluted EPS reaches approximately $13.22. Free cash flow stays negative through FY2027E — the bull case spends more than our base case, not less, because success justifies acceleration — then turns sharply positive to roughly $44B by FY2030E.

Valuation: $13.22 of FY2030E EPS at a 55x exit multiple gives $727 in 2030, discounted 4.5 years at a 9% cost of equity — deliberately lower than our base-case discount rate, because a Tesla that has demonstrated robotaxi economics is a lower-risk business — for approximately $500 today. The 55x exit multiple is defensible in this case because a company growing 24% with Optimus still ahead of it would not be a terminal-multiple business in 2030.

Base — $190 (50% probability). Real growth, slow margin repair, autonomy arrives late.

This is the model detailed in Section 4. Revenue compounds 19.6% to $232B by FY2030E on Cybercab, Semi, Megapack 3 and a services line growing to $58B, of which we estimate $24B is FSD and robotaxi software. Gross margin recovers from 18.0% to 24.5% on mix. But $70B+ of 2026-27 capex arrives as depreciation — D&A tripling from $6.3B to $18.5B — so operating margin recovers only to 11.4% by FY2030E, below the ~17% of FY2022. Free cash flow is -$7.2B in FY2026E, +$1.4B in FY2027E, and does not reach a comfortable level until FY2028E. Diluted EPS: $0.77 → $1.27 → $2.38 → $3.68 → $5.14.

Robotaxi in this case becomes a genuine business but on a slower curve — meaningful revenue from 2028 rather than 2027 — and Optimus remains largely an internal tool through the window, generating limited external revenue.

Valuation: $5.14 of FY2030E EPS at a 57x exit multiple gives $292 in 2030, discounted 4.5 years at 10% for approximately $190 today. We should be explicit that 57x is a generous base-case exit multiple by any conventional standard — we apply it because even in the base case Tesla in 2030 would still hold unmonetised autonomy and robotics optionality, and because Tesla has persistently traded well above conventional multiples. A more orthodox 35x exit produces $117 per share. Cross-check: FY2030E EBITDA of $44.9B at 22x plus net cash, discounted identically, gives roughly $172 — consistent range.

Bear — $60 (25% probability). The capex lands and the autonomy revenue does not.

Robotaxi fails to demonstrate economics that survive insurance, remote-supervision and depreciation loading, or regulatory expansion stalls after a safety event. Optimus slips past 2029 for external revenue. BYD and Chinese competition compress automotive pricing further while the affordable model remains undelivered. Energy tariff pressure persists. Crucially, the 2026-27 capex is already spent in this case — Tesla carries $18B+ of annual depreciation against an automotive business growing high single digits.

Financially: revenue compounds only 10.7% to approximately $158B by FY2030E, gross margin recovers only to 21.5%, operating income reaches roughly $11.2B (7.1% margin), and diluted EPS reaches approximately $1.94. Free cash flow is deeply negative in FY2026E and FY2027E before recovering modestly as capex is cut back to $15-16B.

Valuation: $1.94 of FY2030E EPS at a 37x exit multiple gives $72 in 2030; discounted at 10% and adding roughly $20 per share for residual net cash and the energy franchise gives approximately $60 today. Note that even the bear case applies a growth multiple — we are not modelling Tesla as a 9x automaker, because the brand, the fleet, the charging network and the balance sheet retain real value in any scenario short of catastrophe.

The blend is $235, about 25% below the $313 price. But the more useful way to read the table is as an asymmetry statement. At $313, an investor is paying above the bull-case-adjusted midpoint — the price sits 63% of the way from base to bull. If the bull case is right you make roughly 60%. If the base case is right you lose roughly 39%. If the bear case is right you lose roughly 81%. A 25/50/25 distribution across those outcomes has a negative expected value at today’s price, and that is the whole of our argument.

Probability honesty. Our 25% bull probability is a judgement, not a calculation, and it is the single input most likely to be wrong. A reasonable investor who believes Tesla’s camera-only architecture is decisively ahead of Waymo’s, and that Optimus is closer than management’s own cautious language implies, could hold 40% on the bull case — which produces a Scenario Fair Value near $290 and a Neutral view. We would not argue that person is being unreasonable. What we would argue is that arriving at $313 or higher requires either a bull probability above 50%, or a base case materially better than a company earning $5.14 in 2030. Neither is supported by anything Tesla has disclosed.

6 · Valuation — and the Lab

Our valuation triangulates five methods and reaches a Scenario Fair Value of $235, roughly 25% below the $313.03 price. The most important thing to say about the exercise is methodological: on Tesla, the discounted cash flow model does not work, and we would rather report that than tune it until it agrees with the market.

Method 1: DCF (mid-cycle FCF perpetuity) — $48 to $104, base $64. Weight: 10%.

Discount rate: WACC of 12.7%, built from a cost of equity of 13.2% (risk-free 4.45% + beta 1.75 × ERP 5.0%) at 94% equity weight, plus after-tax cost of debt of 4.3% at 6% weight. The 1.75 beta is already generous — Tesla’s realised beta has run between 1.9 and 2.3 — and we flag that because the discount rate is itself a live argument on this name. Terminal growth: 4.5%, high relative to a mature company and justified by the autonomy and robotics runway beyond 2030.

Explicit-period unlevered free cash flow is negative in FY2027E (-$4,225M) before turning positive: +$6,542M in FY2028E, +$15,191M in FY2029E, +$22,207M in FY2030E. Present value of the explicit period: approximately $25.8B. Normalised mid-cycle unlevered FCF of $24,000M at end-FY2030 gives a terminal value of $307B, present value $190.6B. Enterprise value $216.4B, plus $27B of net cash, over 3,800M diluted shares = $64 per share.

Terminal value is 88% of enterprise value. That is the finding, and it fails the standard 70% sanity check by a wide margin. A DCF in which nine-tenths of the answer sits beyond the explicit forecast is not a valuation; it is a restatement of the terminal assumption. This tells us the method has broken down for a company whose cash flows are negative today and whose value is genuinely optional — it does not tell us Tesla is worth $64. We therefore weight it 10% and report it as evidence about the character of the valuation rather than as a target.

The sensitivity grid in the Lab below makes the point better than prose can. Across WACC from 10.5% to 14.5% and terminal growth from 3.5% to 5.5% — a wide, generous range — every single cell falls between $48 and $104. There is no discount-rate assumption within the bounds of reason that produces $313 from mid-cycle cash flows.

Method 2: DCF with exit multiple — $67 to $115, base $91. Weight: 10%.

Blending the perpetuity terminal with an exit multiple on mid-cycle EBITDA (average FY2028-30E EBITDA of $35.6B) at 14x to 22x produces $67 to $115 per share across a normalised-FCF range of $12B to $36B. To reach $313 on this method you would need mid-cycle unlevered FCF near $36B — that is, FY2030E free cash flow treated as permanent and achieved four years early — combined with a 22x exit multiple. That is the bull case restated as a cash-flow requirement, and stating it that way is more informative than the point estimate.

Method 3: FY2030E EV/EBITDA — $143 to $220. Weight: within the P/E block.

FY2030E EBITDA of $44,937M at 18x to 28x, plus net cash, over 3,900M shares, discounted 4.5 years at 10%, gives $143 to $220 per share. The 18-28x range brackets high-quality growth compounders; Tesla’s current TTM EV/EBITDA is above 100x on our numbers, against 25x on FY2030E EBITDA.

Method 4: FY2030E P/E — $151 to $234, base $190. Weight: 30%.

FY2030E EPS of $5.14 at 45x to 70x, discounted 4.5 years at 10%, gives $151 to $234 per share, with our 57x base case at $190. We use FY2030E rather than FY2026E or FY2027E because the near years are deliberately depressed by the investment cycle — FY2026E EPS of $0.77 at any sane multiple produces a number nobody would publish. Applying a forward multiple to a trough year would be the analytical error the bull case correctly warns against, so we go out to the year where the model shows normalised earnings power.

At $313, Tesla trades at roughly 61x our FY2030E EPS — four years forward — and approximately 290x trailing GAAP EPS of $1.08. The auto and mobility peer block trades at 5x to 16x forward earnings. No multiple applied to any year we can model reaches the market price.

Method 5: Scenario range — $60 to $500, weighted $235. Weight: 50%.

Detailed in Section 5: 25% bull at $500, 50% base at $190, 25% bear at $60. This method carries the highest weight because Tesla’s outcome distribution, not its central estimate, is the actual analytical problem — the street’s own $130 to $600 target range makes that concrete.

Method weighting and the football field. We weight 10% DCF perpetuity / 10% DCF exit multiple / 30% FY2030E P/E / 50% scenario, arriving at $235. The football field below is the single most useful exhibit in this report: $313 sits above the high end of four of the five method ranges. It falls inside only the scenario range, and there only because the bull case is inside it. That is the visual signature of a stock priced on option value rather than on modelled earnings.

Which multiples to actually trust for TSLA

Tesla has eight years of weekly history for seven standard valuation ratios in the kaamos bands data. This sub-section says which we use and why — and it contains the one finding in this report that argues against our own conclusion.

The uncomfortable result first. Tesla is not expensive against its own history. Price-to-sales sits roughly 0.9σ above its eight-year mean. Price-to-book sits almost exactly at its mean. EV/EBITDA is only about 0.3σ above. An investor whose framework is historical mean reversion would look at these bands and conclude Tesla is unremarkable, and on that framework they would be right. We are reporting this prominently rather than burying it because a report that only shows the evidence supporting its conclusion is not research.

Our answer is that Tesla’s eight-year history is itself a history of paying for a future that had not yet arrived. The mean of a series that has always embedded enormous option value is not a valuation floor — it is the average price of the same optimism. Mean reversion tells you where sentiment has typically sat; it cannot tell you whether the option is worth what sentiment paid. That is why the bands inform this report and do not drive it, and why the scenario framework carries 50% weight instead.

Primary — Price/Sales. The only multiple on Tesla with a stable denominator. Diluted EPS has swung from $4.30 (FY2023A, inflated by a $5.9B one-off tax release) to $2.04 to $1.08 in two years on tax one-offs, credit expiry and a deliberate investment cycle — so P/E bands are noise. Revenue is the one line that has compounded through all of it. At roughly 11x trailing sales Tesla sits near the top of its post-2022 range and about 0.9σ above the eight-year mean: expensive, but not the outlier the earnings multiples imply. Read this as the least-distorted measure of what you pay per dollar of business.

Primary — EV/EBITDA (TTM). The bridge between the revenue story and the cash-flow problem. EV/EBITDA captures the operating engine before the capex decision, which is exactly the split this report cares about: the business generating EBITDA is fine, and the capital being spent against it is the question. Above 100x trailing on our numbers against roughly 25x on FY2030E EBITDA of $44.9B, the ratio quantifies how much growth must be delivered before the multiple looks ordinary. The band sits only ~0.3σ above its mean because the mean itself is extraordinary.

Secondary — Price/Book. Included because it is the counter-argument, and because a z-score near zero deserves an explanation rather than an omission. Tesla’s book equity of $86.9B is growing quickly — precisely because $25B a year of capex is capitalising onto the balance sheet — so P/B mechanically compresses as the company spends. A flat P/B therefore measures how much has been invested, not how cheap the stock is. Book value would only become a meaningful anchor if returns on that capex disappointed and assets were impaired, which is the bear case rather than the base case.

Why we excluded the rest. Trailing P/E is roughly 290x on TTM diluted EPS of $1.08, and the eight-year band carries a standard deviation of 371 against a mean of 177 — arithmetically meaningless. P/FCF is undefined on a negative denominator: free cash flow was -$1,092M in Q2-26 and we model -$7,189M for FY2026E. P/CF would flatter Tesla by excluding exactly the capex this report is about — on this name the gap between operating and free cash flow is the story. Dividend yield is a flat zero and will stay there given negative free cash flow and a $30B borrowing programme.

The band charts below show each selected ratio with its ±1σ and ±2σ envelope around the eight-year mean and the current reading marked. One timing caveat: the snapshot predates the 23 July 2026 de-rating, so current readings are roughly 20% higher than where the ratios sit at $313.03.

Analyst-target reference. Post-Q2-26 sell-side targets run from $130 (Wells Fargo) to $600 (Wedbush), against a Hold consensus across roughly 26 analysts and a pre-earnings median near $462. Our $235 Scenario Fair Value sits below the consensus average and well above the Street low. We think the bulls are capitalising robotaxi and Optimus as resolved when no unit economics have been disclosed; we think the $130 bears are under-crediting a genuinely re-accelerating revenue line, a $34B net cash position and a real chance the strategy works. Our number is deliberately closer to the middle of the plausible range than the headline “-25%” implies.

What changes this valuation. Three disclosures would move us materially and quickly: robotaxi unit economics at scale (revenue per vehicle-mile, fleet utilisation, cost per mile including depreciation and remote supervision), Optimus revenue from external customers, or automotive gross margin back above 20% with free cash flow positive. The first is the most valuable, because it converts an unmodellable option into a business an analyst can underwrite — at which point the DCF might start working again and our 10% weight on it would rise. We would also turn constructive on price alone in the $180-200 range, where the bear case is substantially discounted.

7 · Company

Tesla, Inc. (NASDAQ: TSLA) is the world’s most valuable automaker and, increasingly, a company that resists that description. At the current $313.03 share price it carries roughly $1.18 trillion of market capitalisation against FY2025 revenue of $94.8B and FY2025 net income of $3.8B. Those three numbers cannot be reconciled by any conventional automotive framework, and the company does not ask investors to try. Tesla’s own framing — restated in the Q2-26 shareholder letter — is that “hardware-related profits” will be “accompanied by an acceleration of AI, software and fleet-based profits.” The entire investment question is whether that second clause arrives, when, and at what margin.

The business reports in three segments. Automotive ($69.5B in FY2025, 73% of revenue) sells Model 3 and Model Y at volume from four plants — Fremont, Shanghai, Berlin and Austin — with Cybertruck, Cybercab and a forthcoming Semi at much smaller scale. Energy generation and storage ($12.8B, 13%) sells Megapack utility-scale batteries and Powerwall residential units, and is the fastest-growing hardware line by volume: 46.7 GWh deployed in FY2025, up 49%. Services and other ($12.5B, 13%) is a mixed bucket — Supercharging, insurance, used-vehicle sales, parts, merchandise, and the FSD software subscription — and is the segment that grew fastest in Q2-26 at +50% year over year.

The segment mix understates how much the story has moved. In FY2025 automotive revenue fell 10% while energy rose 27% and services rose 19%. In Q2-26 automotive recovered to +23% but services grew 50% and now runs at a $18.3B annualised rate. In our base case, services and energy together grow from 26% of revenue in FY2025A to 39% by FY2030E. The company that reported a 9% decline in deliveries in 2025 is not the same company that reported a 25% increase in Q2-26, and neither is quite the company the market is pricing.

Geographically Tesla discloses only the United States, China and “other” in its 10-K, which is unhelpfully coarse for a business with four continental manufacturing footprints. Our estimated ship-to mix is approximately 47.5% United States, 20.5% mainland China, 17.5% Europe, 7% other Asia-Pacific, and the balance in Canada, Mexico and rest of world. China matters disproportionately for two reasons beyond its revenue share: Shanghai is Tesla’s highest-volume and lowest-cost plant at over 950,000 units of installed annual capacity, and BYD — Tesla’s only genuine competitor at scale — is a Chinese company with roughly 22% of global battery-electric volume against Tesla’s 15%.

Leadership is unusually concentrated. Elon Musk has been CEO since 2008, holds approximately 19.9% of the stock beneficially, and received a 2025 CEO Performance Award of 423,743,904 shares. Vaibhav Taneja has been CFO since 2023 and now owns the two most consequential disclosures at the company: the FY2026 capex guide of more than $25B and the warning that free cash flow stays negative through year-end. Ashok Elluswamy, Vice President of AI Software, runs both Autopilot/FSD and — following Milan Kovac’s departure — the Optimus humanoid programme. That is a remarkable concentration of thesis-critical responsibility in one executive, and worth watching.

The balance sheet is genuinely strong and this deserves emphasis in a report with a Cautious view. As of 30 June 2026 Tesla held $43.5B of cash and short-term investments against $9.3B of total debt and finance leases — a net cash position of roughly $34B, or about $9 per share. Total stockholders’ equity was $86.9B. Tesla can comfortably fund the announced investment programme; management has additionally indicated a willingness to borrow up to $30B to accelerate it. Tesla is not a company at financial risk. Nothing in this report should be read as a solvency argument. The question is narrower and harder: what earnings power should be capitalised, on what horizon, and at what multiple.

One accounting detail belongs in the overview because it recurs throughout this report. In Q1-26 Tesla purchased $2,002M of SpaceX equity — an unlisted company with the same chief executive. In Q2-26 it recognised a $1,005M unrealized gain on that holding, which is why GAAP net income of $1,114M exceeded operating income of $398M. The disclosure is clear and the accounting is permitted. But it means the headline GAAP EPS of $0.32 for the quarter was roughly $0.07 on an operating basis, and it establishes a precedent of Tesla’s reported earnings depending partly on its own valuation of a related private company.

The remainder of this report works through that in order. Section 2 sets out the four thesis pillars. Section 3 reads the financial record, including the Q2-26 print in detail. Sections 4 and 5 build the forward model and the scenario fan around it. Section 6 triangulates valuation and explains why we deliberately de-weight the DCF. Sections 7 and 8 supply the competitive and market context and the downside cases.

Business mix & divisional economics

8 · Risks to the Target

Because our view is Cautious, the most important risks are the ones that would make us wrong. We lead with those.

Risks to our Cautious view

1. Robotaxi economics prove out faster than we model. This is the primary risk and it is substantial. Unsupervised service is live in seven metros, management targets 10% weekly domestic growth, and the claimed safety record — no notable incidents across 380,000 miles — is genuinely impressive for an early-stage autonomous deployment. Tesla’s camera-only, no-pre-mapping architecture, if it works, scales far better than Waymo’s per-market build-out because Tesla can enable vehicles it has already sold. If 2027 rather than 2029 is the year robotaxi economics become visible, our base case is wrong and $500 is the right anchor. We hold 25% on this; 40% would be defensible and would produce a Neutral view at roughly $290.

2. Optimus is a real product sooner than guided. First-generation lines are installed at Fremont with initial runs guided to Q3-26 and external commercialisation to 2027. Our base case gives Optimus almost no revenue through FY2030E. If humanoid robots reach external commercial sale at any meaningful volume within the window, the addressable market is large enough that no valuation framework in this report would constrain the outcome. This is the single largest upside asymmetry we are carrying.

3. Tesla has repeatedly grown into valuations that looked indefensible. In 2019 the stock traded near $28 on a split-adjusted basis with the company close to insolvency. Anyone applying the analysis in this report at various points since would have been wrong for extended periods. Valuation-based caution on Tesla has a poor historical track record, and we hold our view with appropriate humility about that record. A short position on the basis of this analysis would be a materially riskier proposition than the analysis itself supports.

4. The demand signal is genuinely strong. The largest order backlog in company history, production constraints rather than demand constraints, 15 days of inventory, deliveries +25%, and services +50% are not the fingerprints of a decaying franchise. If Tesla resolves the electronics and battery bottlenecks, FY2027 volume could exceed our 2.25 million assumption meaningfully, and operating leverage on a 24.5% gross margin base would flow through faster than we model.

Risks to the company

5. Structural margin impairment from policy reversal. Regulatory-credit revenue fell 67% to $146M in Q2-26 after the $7,500 federal EV credit expired on 30 September 2025 and CAFE penalties were zeroed. That line contributed roughly $2.8B at close to 100% margin in FY2025 — nearly two thirds of FY2025 operating income — and it is gone for structural, not cyclical, reasons. Separately, tariffs took energy gross margin from 39.5% to 20.4% while deployments grew 41%. Both are policy variables outside management’s control and neither is assumed to reverse in our model.

6. The depreciation air pocket in FY2027-28. This is the risk we think is most under-appreciated. Over $70B of capex across 2026-27 arrives on the income statement as depreciation regardless of whether the revenue it enables materialises. PP&E rose $4.0B in Q2-26 alone against quarterly D&A of $1,619M. We model D&A tripling from $6.3B to $18.5B between FY2025A and FY2030E. If revenue growth decelerates from Q2-26’s 26% toward the low teens while that fixed-cost base lands, operating margin could stay in the low single digits well into 2028 — a scenario in which the stock has neither earnings nor a growth narrative to defend it.

7. Competitive pressure from BYD in the segment Tesla does not serve. BYD holds roughly 22% of global BEV volume against Tesla’s 15%, is more vertically integrated, trades at 15x forward earnings on 24% growth, and sells profitably below the Model 3 price point. Tesla’s affordable model received no timeline on the Q2-26 call. Cybertruck’s listed capacity was cut from 300,000 to 125,000 units. Two models generate 97% of Tesla’s volume, and a competitive product aimed squarely at that band has outsized effect.

8. Dilution and governance. Stock-based compensation reached $1,151M in Q2-26 and is rising on the 2025 CEO Performance Award. Weighted-average diluted shares of 3,540M compare with 3,755,723,871 cover-page shares outstanding, including 423,743,904 award shares and 286,428,773 restricted shares subject to service vesting — roughly 6% of the company outside the current diluted count. Separately, Tesla purchased $2,002M of SpaceX equity in Q1-26 and recognised a $1,005M unrealized gain on it in Q2-26, a ~50% markup in one quarter on an unlisted related party sharing Tesla’s chief executive. The accounting is permitted and the disclosure is clear, but Tesla’s reported earnings now depend partly on its own valuation of a private affiliate, and the CEO’s attention is divided across xAI, SpaceX, X and Neuralink.

9. Autonomy regulatory and safety tail risk. A single high-profile fatality involving an unsupervised Tesla robotaxi could halt expansion across multiple jurisdictions and would arrive at a moment when the entire equity value above roughly $100 per share rests on the programme. Camera-only perception carries a heavier regulatory burden of proof than lidar-based approaches after several years of driver-assistance investigations. Approval remains state-by-state in the United States and considerably slower internationally — FSD (Supervised) reached the Netherlands only in April 2026. Separately, Hardware 3 owners who purchased FSD years ago still have no disclosed upgrade path, which is a latent warranty and litigation exposure.

10. Execution concentration and key-person risk. Ashok Elluswamy runs both Autopilot/FSD and, following Milan Kovac’s departure, the Optimus programme — an extraordinary concentration of thesis-critical responsibility in one executive. Elon Musk’s departure or incapacity would be a first-order event for the equity in a way that is true of almost no other company of this size.

11. Financing and rate risk. Tesla plans to borrow up to $30B. Interest expense rises in our model from $337M in FY2025A to $1,900-2,300M annually from FY2027E. That is manageable against a $34B net cash position, but it converts a company with no meaningful leverage into one with real fixed charges precisely as free cash flow goes negative. A materially higher rate environment, or a credit-market disruption during the drawdown period, would tighten the strategy’s funding assumptions.

What we are explicitly not arguing

We are not arguing insolvency risk: net cash of approximately $34B, equity of $86.9B, operating cash flow of $18.3B in FY2026E and access to capital markets make financial distress a remote scenario. We are not arguing the strategy is wrong: spending aggressively to reach a step-change first is the correct behaviour for a company that believes one is close. And we are not arguing the addressable markets are small — they are enormous, which is why our bull case is $500. We are arguing that at $313 the shares already own the successful outcome, and that the distribution of outcomes around that price is unattractive.

Catalysts to watch

• {'when': 'Q3 2026', 'what': 'First Optimus production runs at Fremont — the test is whether units exist and what they are used for'}
• {'when': 'Oct 2026', 'what': "Q3-26 earnings — first clean read on H2 capex, FCF burn, and whether Q2's backlog converted"}
• {'when': 'Q4 2026', 'what': 'Tesla Semi production start and Megapack 3 ramp; Cybercab first customer deliveries still unscheduled'}
• {'when': 'Q4 2026', 'what': 'Robotaxi expansion to Phoenix and Las Vegas; watch for any disclosure of per-mile economics'}
• {'when': 'Jan 2027', 'what': 'FY2026 10-K — full-year capex, the SpaceX stake carrying value, and FY2027 capex guidance'}
• {'when': '2027', 'what': 'Guided external commercialisation of Optimus — the single largest swing factor in our scenario set'}

Upcoming events

• 2026-07-23 — Shares fall 14.5% to $319.69 (Roughly $140B of market value erased — one of the sharpest single-day declines in over a year)
• 2026-07-22 — Q2-26 results (Record revenue $28.2B (+26%); op margin 1.4%; non-GAAP EPS $0.33 vs ~$0.53 consensus; FCF -$1.1B; FY26 capex guide raised above $25B)
• 2026-04-22 — Q1-26 results (Revenue $22.4B (+16%), gross margin 21.1%, FCF +$1.4B; deliveries 358,023 missed and inventory rose to 27 days)
• 2026-04-01 — Cybercab continuous production begins at Giga Texas (Installed capacity listed above 125,000 units; no customer deliveries yet)
• 2026-01-28 — FY2025 results (Revenue $94.8B (-3%), deliveries 1.64M (-9%), operating income $4.4B (-38%); FY26 capex first guided to $20B)
• 2025-09-30 — $7,500 federal EV tax credit expires (Pulled demand into Q3-25 (497,099 deliveries) and structurally removed near-100%-margin credit revenue)